Cubic phase gels as drug delivery systems

Advanced Drug Delivery Reviews
J C ShahD M Chilukuri

Abstract

Lipids have been used extensively for drug delivery in various forms such as liposomes, and solid-matrices. The focus of this review is evaluation of liquid crystalline cubic phases, spontaneously formed when amphiphilic lipids are placed in aqueous environment, for drug delivery. Cubic phases have an interesting thermodynamically stable structure consisting of curved bicontinuous lipid bilayer in three dimensions, separating two congruent networks of water channels. The unique structure of cubic phase has been extensively studied using various spectroscopic techniques and their resemblance to biomembranes has prompted many scientists to study behavior of proteins in cubic phases. The ability of cubic phase to incorporate and control release of drugs of varying size and polar characteristics, and biodegradability of lipids make it an interesting drug delivery system for various routes of administration. Cubic phases have been shown to deliver small molecule drugs and large proteins by oral and parenteral routes in addition to local delivery in vaginal and periodontal cavity. A number of different proteins in cubic phase appear to retain their native conformation and bioactivity, and are protected from chemical and physical inac...Continue Reading

References

Nov 1, 1988·Chemistry and Physics of Lipids·K Larsson
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D M AndersonS Leibler
Mar 23, 1983·Biochimica Et Biophysica Acta·B EricssonK Fontell
Jan 1, 1993·Biophysical Journal·P O Eriksson, G Lindblom
Nov 1, 1995·Biophysical Journal·H Chung, M Caffrey
Dec 4, 1996·Biochimica Et Biophysica Acta·S B LesileA S Rudolph
Jun 1, 1997·Journal of Pharmaceutical Sciences·C M Chang, R Bodmeier
Jun 12, 1997·Biochimica Et Biophysica Acta·R KoynovaG Rapp
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·E S ParkJ C Shah
Oct 31, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·L S NielsenJ Hansen
Jul 30, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S EngströmH Nyquist
Sep 3, 1999·FEBS Letters·P NollertE M Landau
Nov 11, 1999·International Journal of Pharmaceutics·Y Sadhale, J C Shah
Nov 11, 1999·International Journal of Pharmaceutics·Y Sadhale, J C Shah

❮ Previous
Next ❯

Citations

Nov 9, 2012·Pharmaceutical Research·Jaclyn M HosmerLuciana B Lopes
May 7, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mirjam GosencaMirjana Gašperlin
Mar 17, 2004·International Journal of Pharmaceutics·Kiran Kumar MAnant Paradkar
Mar 22, 2005·International Journal of Pharmaceutics·Marilisa G LaraJohn H Collett
Apr 9, 2005·International Journal of Pharmaceutics·Manish H Shah, Anant Paradkar
Mar 26, 2013·International Journal of Pharmaceutics·J C BodeH Bunjes
Dec 29, 2013·Journal of Colloid and Interface Science·Abdelkader MouriPhilippe Legrand
Apr 11, 2003·Journal of Colloid and Interface Science·Matthew L LynchPatrick T Spicer
Sep 3, 2002·International Journal of Pharmaceutics·Britta SiekmannKirsten Westesen
Jul 5, 2003·International Journal of Pharmaceutics·Ben J Boyd
Jul 5, 2003·International Journal of Pharmaceutics·E EspositoR Cortesi
Oct 28, 2010·Journal of the American Chemical Society·Sergio MurgiaMaura Monduzzi
Jan 14, 2012·Journal of the American Chemical Society·Takahiro IchikawaTakashi Kato
Jun 24, 2011·The Journal of Physical Chemistry. B·Kamendra P SharmaGuruswamy Kumaraswamy
Apr 2, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Renata Negrini, Raffaele Mezzenga
Apr 22, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Alexandru ZabaraRaffaele Mezzenga
Aug 19, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Chandrashekhar V Kulkarni
Jun 15, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Chandrashekhar V KulkarniOtto Glatter
Jan 11, 2003·Biotechnology & Genetic Engineering Reviews·Walter MaglianiLuciano Polonelli
Jun 27, 2006·AAPS PharmSciTech·Saurabh Jauhari, Alekha K Dash
May 6, 2008·AAPS PharmSciTech·Fabiana T M C VicentiniMaria J V Fonseca
Jan 1, 2014·International Journal of Nanomedicine·Devasier BennetSanghyo Kim
Jul 28, 2012·Journal of Advanced Pharmaceutical Technology & Research·Rasmané SemdéMoustapha Ouédraogo
Jan 29, 2014·Chemical Communications : Chem Comm·Alexandru ZabaraRaffaele Mezzenga
Jan 22, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Ewa NazarukEhud M Landau
Mar 29, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Renata NegriniRaffaele Mezzenga
May 3, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Wye Khay FongBen J Boyd
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Min-Hyo KiDae-Duk Kim
Apr 15, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lívia Neves Borgheti-CardosoMaria Vitória Lopes Badra Bentley
Jul 23, 2013·International Journal of Pharmaceutics·T T H PhamG Barratt
May 23, 2014·Pharmaceutical Research·Preety SahdevJames J Moon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.